Literature DB >> 8755639

Interactions between insulin-like growth factor-I (IGF-I) and the renin-angiotensin system in follicular growth and ovulation.

Y Yoshimura1, N Aoki, K Sueoka, T Miyazaki, N Kuji, M Tanaka, T Kobayashi.   

Abstract

The interactions between insulin-like growth factor-I (IGF-I) and the renin-angiotensin system (RAS) in follicular growth and ovulation were studied with the use of an isolated perfused rabbit ovary preparation. Ovulation failed to occur in either control ovaries or the experimental ovaries perfused with IGF-I in a concentration of 1, 10, or 100 ng/ml in the absence of gonadotropin. Exposure to IGF-I stimulated the secretion rate of angiotensin II-like immunoreactivity (Ang II-IR) in perfused rabbit ovaries in a dose-dependent manner. The percent increase in follicle diameter in ovaries perfused with IGF-I for 12 h was significantly correlated with the secretion rate of Ang II-IR at 12 h after exposure to IGF-I. The addition of IGFBP-3 to the perfusate did not induce ovulation in the absence of gonadotropin, but exposure to IGFBP-3 inhibited hCG-induced ovulation in a dose-dependent manner. In addition, IGFBP-3 significantly reduced the ovarian secretion rate of Ang II-IR and prostaglandins stimulated by hCG administration. Intrafollicular plasminogen activator (PA) activity significantly increased within 4 h after exposure to 100 ng/ml of IGF-I, compared with that in control ovaries perfused with medium alone. The concomitant addition of IGFBP-3 to the perfusate significantly reduced the IGF-I-stimulated PA activity in the preovulatory follicles at 4, 6, and 8 h after exposure to IGF-I. However, IGFBP-3 alone affected neither the ovarian secretion rate of Ang II-IR nor intrafollicular PA activity. Exposure to streptokinase, an exogenous PA, in vitro stimulated both follicular growth and the intrafollicular Ang II-IR content. In conclusion, IGF-I enhances both ovarian Ang II production and follicular development by stimulating intrafollicular PA activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8755639      PMCID: PMC507432          DOI: 10.1172/JCI118794

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  47 in total

1.  The effects of proteolytic enzymes on in vitro ovulation in the rabbit.

Authors:  Y Yoshimura; R Santulli; S J Atlas; S Fujii; E E Wallach
Journal:  Am J Obstet Gynecol       Date:  1987-08       Impact factor: 8.661

2.  Sequential changes in plasma luteinizing hormone and plasma prorenin during the menstrual cycle.

Authors:  J E Sealey; I Cholst; N Glorioso; C Troffa; I D Weintraub; G James; J H Laragh
Journal:  J Clin Endocrinol Metab       Date:  1987-07       Impact factor: 5.958

3.  The 25-kilodalton insulin-like growth factor (IGF)-binding protein inhibits both basal and IGF-I-mediated growth of chick embryo pelvic cartilage in vitro.

Authors:  W M Burch; J Correa; J E Shively; D R Powell
Journal:  J Clin Endocrinol Metab       Date:  1990-01       Impact factor: 5.958

Review 4.  Intragonadal regulation of follicular maturation.

Authors:  S A Tonetta; G S diZerega
Journal:  Endocr Rev       Date:  1989-05       Impact factor: 19.871

5.  An insulin-like growth factor-binding protein in ovarian follicular fluid blocks follicle-stimulating hormone-stimulated steroid production by ovarian granulosa cells.

Authors:  M Ui; M Shimonaka; S Shimasaki; N Ling
Journal:  Endocrinology       Date:  1989-08       Impact factor: 4.736

6.  Insulin-like growth factor-I regulates aromatase activity in human granulosa and granulosa luteal cells.

Authors:  G F Erickson; V G Garzo; D A Magoffin
Journal:  J Clin Endocrinol Metab       Date:  1989-10       Impact factor: 5.958

7.  Prolactin inhibits plasminogen activator activity in the preovulatory follicles.

Authors:  Y Yoshimura; K Maruyama; M Shiraki; S Kawakami; M Fukushima; Y Nakamura
Journal:  Endocrinology       Date:  1990-01       Impact factor: 4.736

8.  Insulin-like growth factor I gene expression in the rat ovary is confined to the granulosa cells of developing follicles.

Authors:  J E Oliver; T J Aitman; J F Powell; C A Wilson; R N Clayton
Journal:  Endocrinology       Date:  1989-06       Impact factor: 4.736

9.  Suppression of ovulation rate by antibodies to tissue-type plasminogen activator and alpha 2-antiplasmin.

Authors:  A Tsafriri; T A Bicsak; S B Cajander; T Ny; A J Hsueh
Journal:  Endocrinology       Date:  1989-01       Impact factor: 4.736

10.  Blockage of ovulation by an angiotensin antagonist.

Authors:  A Pellicer; A Palumbo; A H DeCherney; F Naftolin
Journal:  Science       Date:  1988-06-17       Impact factor: 47.728

View more
  3 in total

1.  Angiotensin-converting enzyme (ACE) inhibition attenuates insulin-like growth factor-I (IGF-I) induced cardiac fibroblast proliferation.

Authors:  M van Eickels; H Vetter; C Grohé
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

Review 2.  Insulin-like growth factors and their binding proteins: Potential relevance to reproductive physiology.

Authors:  Yasunori Yoshimura
Journal:  Reprod Med Biol       Date:  2003-03-25

Review 3.  Recent discoveries in physiology of insulin-like growth factor-1 and its interaction with gonadotropins in folliculogenesis.

Authors:  F Khamsi; S Roberge; Y Yavas; I C Lacanna; X Zhu; J Wong
Journal:  Endocrine       Date:  2001-12       Impact factor: 3.633

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.